NHS England has launched a groundbreaking vaccination program to combat the rise of gonorrhoea cases. The program aims to protect thousands of individuals from this sexually transmitted infection, which reached record levels in 2023 with 85,000 diagnoses. The vaccine, based on the existing meningococcal disease vaccine, is also expected to address the increasing challenge of antibiotic-resistant strains of gonorrhoea.
This initiative, which started on August 4th, is projected to save up to £7.9 million over the next ten years. Minister for Public Health and Prevention, Ashley Dalton, lauded the program as a significant breakthrough in tackling the infection’s escalating rates.
Gonorrhoea is a common STI transmitted through unprotected sex. Symptoms usually appear within two weeks of infection and can include painful urination, genital discharge, and discomfort in the lower abdomen and groin.
The vaccine is targeted at individuals most at risk of contracting the infection, particularly gay and bisexual men with a history of multiple sexual partners. Eligible patients may also receive vaccines for other STIs like syphilis, hepatitis, and HPV.
The vaccine is available at sexual health clinics across England, with the nearest clinics easily locatable online. The program offers the vaccine free of charge, with the vaccination expected to be accessible in all regions by September 4, 2025.
Overall, the introduction of the gonorrhoea vaccine represents a critical step forward in public health efforts against STIs. The program’s accessibility and potential to save lives make it an essential addition to sexual health initiatives in England.
Peace Nero is a writer and blogger who loves to explore different topics of self-development. She shares her personal experiences in order to help people discover their true purpose in life.